PRESS RELEASE published on 09/04/2025 at 16:15, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.71% stake in Qualcomm Incorporated per Form 8.3. Details of positions and dealings included Securities Form 8.3 Position Disclosure Vanguard Group Inc. Qualcomm Incorporated
BRIEF published on 09/04/2025 at 16:15, 1 year ago The Vanguard Group Discloses Position in Greencore Group Form 8.3 Takeover Code Vanguard Group Bakkavor Group Greencore Group
PRESS RELEASE published on 09/04/2025 at 16:14, 1 year ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 7.54% stake in American Axle & Manufacturing Holdings, Inc. as of 03 September 2025. Additional disclosure related to Dowlais Group plc The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Dowlais Group Plc American Axle & Manufacturing Holdings, Inc.
BRIEF published on 09/04/2025 at 16:14, 1 year ago The Vanguard Group Reports on Apax Global Alpha Limited Positions Form 8.3 Takeover Code Securities Disclosure Vanguard Group Apax Global Alpha
BRIEF published on 09/04/2025 at 16:13, 1 year ago Vanguard Group Discloses Deliveroo Position Form 8.3 Takeover Code Securities Disclosure Vanguard Group Deliveroo Investment
PRESS RELEASE published on 09/04/2025 at 16:13, 1 year ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 4.96% stake in JTC plc as of 03/09/2025. Details of securities holdings and recent dealings included Securities Disclosure The Vanguard Group Dealings JTC Plc
PRESS RELEASE published on 09/04/2025 at 16:11, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 4.47% stake in Mural Oncology plc through Form 8.3 with no other party disclosures. Details on interests and short positions provided Form 8.3 The Vanguard Group Stake Disclosure Mural Oncology Plc Interests And Short Positions
BRIEF published on 09/04/2025 at 16:11, 1 year ago The Vanguard Group Discloses Position in Dowlais Group plc Takeover Code Securities Disclosure Vanguard Group Stock Holdings Dowlais Group
PRESS RELEASE published on 09/04/2025 at 16:10, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.33% stake in Greencore Group plc per Form 8.3 under Rule 8.3 of the Takeover Code Form 8.3 Disclosure Takeover Code Vanguard Group Greencore Group Plc
BRIEF published on 09/04/2025 at 16:10, 1 year ago The Vanguard Group Reports Stake in Empiric Student Property Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Empiric Student Property
Published on 09/12/2026 at 02:35, 2 days 2 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days 6 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days 7 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 12 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/14/2026 at 04:40, 31 minutes ago ZPMC Showcases Offshore Engineering Capabilities at SMM 2026 in Hamburg
Published on 09/14/2026 at 02:05, 3 hours 6 minutes ago Shanghai Electric Secures First Overseas Heavy-Duty Gas Turbine Order for 500 MW Malaysian Project
Published on 09/12/2026 at 17:50, 1 day 11 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 21 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 2 days 6 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 07:00, 2 days 22 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 9 hours ago Availability of the 2026 Interim Financial Report